Monoclonal antibody offers strong malaria protection in children
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 Today in the New England Journal of Medicine a study demonstrates that a single subcutaneous (just-under-the-skin) injection of an experimental malaria monoclonal antibody offered up to 77% protection against malaria for children in Mali during a 6-month malaria season. The monoclonal antibody, L9LS, was developed by scientists at the National Institutes of Health (NIH), and was previously shown to offer 80% protection to adults in a phase